ガイドライン

(旧版)食道癌診断・治療ガイドライン 2007年4月版

書誌情報
VII.化学療法

 
【参考文献】
190) Edzinli EZ, et al: Chemotherapy of advanced esophageal carcinoma: Eastern Cooperative Oncology Group experience. Cancer 46:2149-53,1980
191) Lokich JJ, et al: Sequential infusional 5-fluorouracil followed by concomitant radiation for tumors of the esophagus and gastroesophageal junction. Cancer 60:275-9,1987
192) Engstrom PF, et al: Phase II evaluation of mitomycin and cisplatin in advanced esophageal carcinoma. Cancer Treat Rep 67:713-5,1983
193) Wittes RE, et al: Compilation of phase II results with single antineoplastic agents. Cancer Treatment Symposia 4:91-130,1985
194) Murthy SK, et al: Neoadjuvant Cis-DDP in esophageal cancers: an experience at a regional cancer centre, India. J Surg Oncol 45:173-6,1990
195) Bleiberg H, et al: Randomised phase II study of cisplatin and 5-fluorouracil (5-FU) versus cisplatin alone in advanced squamous cell oesophageal cancer. Eur J Cancer 33:1216-20,1997
196) Whittington RM, et al: Clinical experience with mitomycin C (NSC-26980). Cancer Chemother Rep 54:195-8,1970
197) Bonadonna G, et al: Clinical trials with bleomycin in lymphomas and in solid tumors. Eur J Cancer 8:205-15,1972
198) Ravry M, et al: Treatment of advanced squamous cell carcinoma of the gastrointestinal tract with bleomycin (NSC-125066). Cancer Chemother Rep 57:493-5,1973
199) Yagoda A, et al: Bleomycin, an antitumor antibiotic. Clinical experience in 274 patients. Ann Intern Med 77:861-70,1972
200) Kelsen DP, et al: Vindesine in the treatment of esophageal carcinoma: a phase II study. Cancer Treat Rep 63:2019-21,1979
201) Bedikian AY, et al: Phase II evaluation of vindesine in the treatment of colorectal and esophageal tumors. Cancer Chemother Pharmacol 2:263-6,1979
202) Bezwoda WR, et al: Treatment of esophageal cancer with vindesine: an open trial. Cancer Treat Rep 68:783-5,1984
203) Kolarić K, et al: Adriamycin alone and in combination with radiotherapy in the treatment of inoperable esophageal cancer. Tumori 63:485-91,1977
204) Alberts AS, et al: Trimetrexate in advanced carcinoma of the esophagus. Invest New Drugs 6:319-21,1988
205) Ajani JA, et al: Activity of taxol in patients with squamous cell carcinoma and adenocarcinoma of the esophagus. J Natl Cancer Inst 86:1086-91,1994
206) Muro K, et al: A phase II study of single-agent docetaxel in patients with metastatic esophageal cancer. Ann Oncol 15:955-9,2004
207) 田口鐵男,他:254-S(Cis-diammine glycolate platinum)の消化器癌に対する第II相臨床試験.癌と化学療法 19:483-8,1992
208) Ajani JA: Contributions of chemotherapy in the treatment of carcinoma of the esophagus:results and commentary. Semin Oncol 21:474-82,1994
209) Scanlon KJ, et al: Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci U S A 83:8923-5,1986
210) Byfield JE (Lokich JJ ed.): Combined modality infusional chemotherapy with radiation. Cancer chemotherapy by infusion, 2nd ed: Percepta Press (Chicago), p521-51,1990
211) Douple EB, et al (Prestayko AW, Crooke ST, Karter SK eds.): A review of interactions between platinum coordination complexes and ionizing radiation: implication for cancer therapy. Cisplatin, Current Status and New Developments: FL Academic (Orland), 125-47,1980
212) Hilgenberg AD, et al: Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus. Ann Thorac Surg 45:357-63,1988
213) Ajani JA, et al: Prolonged chemotherapy for localised squamous carcinoma of the oesophagus. Eur J Cancer 28A:880-4,1992
214) Iizuka T, et al: Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese Esophageal Oncology Group Trial. Jpn J Clin Oncol 22:172-6,1992
215) Levard H, et al: 5-Fluorouracil and cisplatin as palliative treatment of advanced oesophageal squamous cell carcinoma. A multicentre randomised controlled trial. The French Associations for Surgical Research. Eur J Surg 164:849-57,1998
216) Van der Gaast A, et al: A phase I dose finding study of a biweekly schedule of a fixed dose of cisplatin with increasing doses of paclitaxel in patients with advanced esophageal cancer. Semin Oncol 24:S19-82-S19-85,1997
217) Ilson DH, et al: Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus. J Clin Oncol 16:1826-34,1998
218) Ilson DH, et al: Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer. J Clin Oncol 17:3270-5,1999
219) Millar J, et al: Phase II study of gemcitabine and cisplatin in locally advanced/metastatic oesophageal cancer. Br J Cancer 93:1112-6,2005
220) 室 圭:進行および切除後再発食道癌に対するNedaplatin+5-FU併用療法の第II相臨床試験―JCOG9905―.癌の臨床 50:269-75,2004

 

書誌情報